NewGenIvf Group Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of August 2026 for NewGenIvf Group Limited, a foreign private issuer headquartered in Bangkok, Thailand. The report details a corporate action approved by the Board of Directors on July 31, 2026, regarding a reverse stock split.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure adjustments rather than operational financial performance.
Material Changes
- Reverse Stock Split: A 1-for-3 reverse stock split was approved for all issued and unissued shares (Class A Ordinary Shares, Class B Ordinary Shares, and Preferred Shares).
- Share Count Reduction: The number of outstanding Class A Ordinary Shares will decrease from 6,307,870 to approximately 2,102,623.
- Effective Date: The split becomes effective at 12:01 a.m. (ET) on September 1, 2026.
- Trading Adjustments: Shares will trade on the Nasdaq Capital Market under the symbol "NIVF" with a new CUSIP number (G0544E154) starting September 1, 2026.
- Derivatives Adjustment: Outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable share count by three.
- Fractional Shares: No fractional shares will be issued; shareholders entitled to fractions will receive one full post-split share.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors beyond the mechanics of the stock split. The Board noted that no shareholder vote is required under the BVI Business Companies Act and the Company's M&A.
Investor Verification Checklist
- Confirm the new CUSIP number (G0544E154) for trading purposes on September 1, 2026.
- Verify the adjusted share count in brokerage accounts post-split.
- Review the terms of any outstanding options or warrants to confirm the 1-for-3 adjustment ratio.
- Check for any subsequent filings regarding the impact of the split on the company's compliance with Nasdaq listing standards.